Aclarion Reports Stronger Positioning After Q1 Initiatives

Aclarion Inc. (Nasdaq: ACON, ACONW), the Broomfield healthcare technology company focused on chronic low back pain, announced an update on its improved positioning following successful strategic initiatives in the first quarter of 2025. The company raised over $20 million in Q1, maintaining nearly $15 million in cash on hand. Aclarion reported a clean capital structure,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here